Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $479,700.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $15.99, for a total value of $479,700.00. Following the sale, the president now owns 2,417,700 shares in the company, valued at approximately $38,659,023. The trade was a 1.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.40, for a total value of $271,174.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Price Performance

Shares of ALHC stock traded up $0.45 during trading hours on Friday, reaching $17.63. 1,692,230 shares of the company were exchanged, compared to its average volume of 1,418,653. The stock's fifty day moving average is $14.79 and its two-hundred day moving average is $12.63. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $17.74. The company has a market cap of $3.38 billion, a price-to-earnings ratio of -23.00 and a beta of 1.49. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Remove Ads

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently bought and sold shares of the business. R Squared Ltd bought a new stake in shares of Alignment Healthcare during the fourth quarter worth $55,000. RiverPark Advisors LLC bought a new position in Alignment Healthcare in the fourth quarter valued at $106,000. Tower Research Capital LLC TRC grew its position in Alignment Healthcare by 146.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after purchasing an additional 6,286 shares in the last quarter. Ballentine Partners LLC bought a new position in shares of Alignment Healthcare in the 4th quarter valued at about $121,000. Finally, Aigen Investment Management LP bought a new position in shares of Alignment Healthcare in the 4th quarter valued at about $129,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Piper Sandler lifted their target price on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a report on Tuesday, March 4th. Barclays raised their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research report on Friday, February 28th. Bank of America upped their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a research note on Tuesday, March 4th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a research note on Thursday, March 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.